These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 6994788)

  • 41. Pharmacology of guanfacine.
    Scholtysik G
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):21S-24S. PubMed ID: 6249333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
    Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Central hypotensive effects of guanfacine in anaesthetised rabbits (author's transl)].
    Ohkubo K; Suzuki K; Oguma M; Otorii T
    Nihon Yakurigaku Zasshi; 1982 Apr; 79(4):263-74. PubMed ID: 7047324
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Guanfacine and clonidine: the effects on adrenal medullary function in spontaneously hypertensive rats.
    Togashi H; Minami M; Saito I; Sano M
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):79-87. PubMed ID: 6393888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical pharmacology of the antihypertensive action of guanfacine].
    Safar M; Weiss Y; Georges D
    Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1171-7. PubMed ID: 6778409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antihypertensive effect of guanfacine: a double-blind cross-over trial compared with clonidine.
    Distler A; Kirch W; Lüth B
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):49S-53S. PubMed ID: 6994778
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.
    Zschiedrich H; Neurohr W; Lüth JB; Philipp T; Distler A
    Klin Wochenschr; 1983 Jul; 61(13):661-7. PubMed ID: 6310204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Minimal useful dose of guanfacine in patients with essential hypertension].
    Pérez Olea J; Ortíz N; Soledad Bertoló M; Allel L; Goity C; Quevedo M
    Rev Med Chil; 1985 May; 113(5):420-4. PubMed ID: 3912882
    [No Abstract]   [Full Text] [Related]  

  • 49. Sympathetic responsiveness and antihypertensive effect of beta-receptor blockade in essential hypertension.
    Distler A; Keim HJ; Cordes U; Philipp T; Wolff HP
    Am J Med; 1978 Mar; 64(3):446-51. PubMed ID: 25017
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies on clonidine and guanfacine withdrawal after short term treatment in the rat.
    Barber ND; Reid JL
    Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):112-8. PubMed ID: 6758716
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prolactin, renin, growth hormone, lipoproteins and glucose under guanfacine treatment.
    Hauger-Klevene JH; Balossi EC; Scornavacchi JC
    Cor Vasa; 1987; 29(4 Suppl 1):17-22. PubMed ID: 3119290
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The hypotensive activity and side effects of methyldopa, clonidine, and guanfacine.
    van Zwieten PA; Thoolen MJ; Timmermans PB
    Hypertension; 1984; 6(5 Pt 2):II28-33. PubMed ID: 6094346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Duration of the hypotensive effect of guanfacine.
    Magometschnigg D; Bonelli J; Gassner A; Hitzenberger G; Lenzhofer R; Kleinberger G; Pall H
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):174-8. PubMed ID: 7042594
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical dose-response studies with guanfacine (BS 100-141), a new antihypertensive agent.
    MacCarthy P; Isaac P; Frost G; Freeman A; Stokes G
    Clin Exp Pharmacol Physiol; 1978; 5(2):187-90. PubMed ID: 348364
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A postmarketing evaluation of guanfacine hydrochloride in mild to moderate hypertension.
    Board AW; Perry VP; Shepperson BE; Nyman CE; Carchman SH
    Clin Ther; 1988; 10(6):761-75. PubMed ID: 3064907
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative study of two antihypertensive agents: guanfacine and guanethidine.
    Szám I; Kállay K
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):85S-87S. PubMed ID: 6994786
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Small and large doses of guanfacine (Estulic Sandoz) in the treatment of hypertension.
    Mayer O; Polívková H
    Cor Vasa; 1987; 29(4 Suppl 1):37-41. PubMed ID: 3315449
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antihypertensive effects and plasma levels of guanfacine in man.
    Safar ME; Loria Y; Weiss YA; Boutier JR
    J Clin Pharmacol; 1982; 22(8-9):385-90. PubMed ID: 6752213
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Use of the hypotensive drug guanfacine in the treatment of patients with hypertension].
    Kravchenko IG; Liashenko MM; Tarnakin AG; Chirkov SN
    Kardiologiia; 1986 Mar; 26(3):41-5. PubMed ID: 3520085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clonidine and guanfacine in hypertension.
    Jain AK; Hiremath A; Michael R; Ryan JR; McMahon FG
    Clin Pharmacol Ther; 1985 Mar; 37(3):271-6. PubMed ID: 3882307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.